Vincenza sells VRX 117.39: Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements
LAVAL, Quebec, July 21, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) has contacted both the Autorite des marches financiers ("AMF") in Quebec and the U.S. Securities and Exchange Commission ("SEC ... ...
36 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home